Skip to main content

Day: September 7, 2020

Orthopedic Implants Market to Register a CAGR of 4.1% till 2026 and Reach USD 64.0 Billion by 2026; Increasing Incidence of Osteoporosis to Fuel the Market: Fortune Business Insights

Pune, Sept. 07, 2020 (GLOBE NEWSWIRE) — The global orthopedic implants market size is set to touch USD 64.0 billion by 2026, exhibiting a modest CAGR of 4.1% during the forecast period.Unprecedented rise in geriatric population across the globe to be the key growth driver of this market. According to the United States Census Bureau (USCB), the proportion of aged people to the total world population is steadily climbing. For example, in 2012, world population had reached 7 billion and the people aged 65 and above were 8% of this number or 562 million.In 2015, the number rose by 55 million, with the percentage increasing to 8.5% of the total population in a span of 3 years. The USCB predicts that between 2025 and 2050, this geriatric population will double to reach 1.6 billion, whilst the total population will grow only by 34%. This,...

Continue reading

Botulinum Toxin Market to Witness 8.0% CAGR and Reach USD 8,309.0 Million by 2026; Applications in Therapeutic Procedures to Enable Growth, says Fortune Business Insights

Pune, Sept. 07, 2020 (GLOBE NEWSWIRE) — The global botulinum toxins market size was valued at US$ 4,490.0 Mn in 2018. Fortune Business Insights states that the market will reach 8,309.0 Mn by 2026, exhibiting a CAGR of 8.0%.Botulinum toxins are widely used for improving aesthetic appearances. The effectiveness of botulinum toxins in aesthetic applications such as treatment of moderate to severe glabellar lines have significantly contributed to the global botulinum toxin market growth. Anticipated regulatory approvals in therapeutic applications have led to significant botulinum toxins market growth.The increasing research and development initiatives aimed at the betterment of existing treatment methods, in addition to new methods, will favor growth of the market in the coming years. The high effectiveness of botulinum toxins in...

Continue reading

Ophthalmic Devices Market to Hit USD 32.36 Billion by 2027; Increasing Prevalence of Eye Disorders Worldwide to Favor Growth: Fortune Business Insights™

Pune, Sept. 07, 2020 (GLOBE NEWSWIRE) — The global ophthalmic devices market size is expected to showcase an exponential growth by reaching USD 32.36 billion by 2027 while exhibiting a CAGR of 4.2% between 2020 and 2027. This is attributable to the increasing prevalence of eye disorders across the globe. Fortune Business Insights, in its latest report, titled, “Ophthalmic Devices Market Size, Share & COVID-19 Impact Analysis, By Surgical (Implants, Consumables, and Equipment) and Vision Care (Contact Lenses and Ocular Health) By End User (Hospitals, Ophthalmic Clinics and Others) Regional Forecast, 2020-2027,” observes that the market stood at USD 25.04 billion in 2019 and is projected to showcase a considerable growth in the forthcoming years.Ophthalmology generally deals with the function, structure, and several eye diseases....

Continue reading

Crawler Dozers Market to Reach USD 10.22 billion by 2027; Increasing Number of Product Launches are Driven by Massive Investments in Technological Intervention, says Fortune Business Insights™

Pune, Sept. 07, 2020 (GLOBE NEWSWIRE) — The global crawler dozers market size is projected to reach USD 10.22 billion by the end of 2027. The increasing number of product launches will have a massive impact on the growth of the overall market in the coming years. According to a report published by Fortune Business Insights, titled “Crawler Dozers Market Size, Share & COVID-19 Impact Analysis, By Horsepower (Less than 300 HP, 300 – 600 HP & More than 600 HP), By Application (Construction, Mining, Agriculture & Others), and Regional Forecast, 2020-2027,” the market was worth USD 6.51 billion in 2019 and will exhibit a CAGR of 5.9% during the forecast period, 2020-2027.Crawler dozers are trailed machines that are used to move large quantities and volume of material such as sand, soil, and rubble. The operation...

Continue reading

PGS Sells Towed Streamer CSEM Capability to OFG

September 7, 2020: PGS and Ocean Floor Geophysics, Inc (“OFG”) have today signed an agreement under which OFG has acquired the exclusive rights to use the hardware, software and intellectual property associated with the PGS towed streamer CSEM system. PGS receives shares in OFG as settlement for the transaction.The towed-streamer CSEM technology developed by PGS is a state-of-the-art system that allows for the acquisition of high-quality marine CSEM data in a fast and efficient manner. The system complements existing CSEM technology to permit a broad operating envelope.“We are delighted to have entered into this agreement and to be in a position to add the PGS towed streamer to our OFG Multiphysics division. Over the last few months we polled many of the oil and gas companies that are experienced users of CSEM and were pleased at the...

Continue reading

GOGL – Transition of Chief Financial Officer

Golden Ocean Group Limited (NASDAQ and OSE: GOGL) (“Golden Ocean” or the “Company“) today announced that Mr. Per Heiberg, Chief Financial Officer of Golden Ocean Management AS, has submitted his notice of resignation. Mr. Heiberg has held this position since April 2016 and has worked for the company in various capacities since July 2005.The Company also announced that Peder Simonsen has been appointed as the new CFO of Golden Ocean Management AS. Mr. Simonsen was most recently the Chief Financial Officer and Interim Chief Executive Officer of Avance Gas AS. Prior to joining Avance Gas AS in 2014, he was First Vice President at Nordea Bank Norge ASA, where he worked with numerous large shipping and offshore companies.Mr. Ulrik Andersen, Chief Executive Officer of Golden Ocean Management AS commented: “Per has made a huge contribution...

Continue reading

Avance Gas – Changes to Management and Board

Avance Gas Holding Ltd (“Avance Gas” or the “Company”) announces the following changes to management and board;Mr Peder Carl Gram Simonsen will step down as interim CEO and CFO. Mr Simonsen will be retained as an advisor to Avance for a period to secure continuity. Mr Ben Martin is appointed as the Chief Commercial Officer (CCO) of Avance Gas. Mr. Martin has extensive experience from both LNG and LPG, currently as Chief Commercial Officer in Flex LNG, a role he will continue to hold. Prior to joining Flex, Ben served as Head of Chartering for LNG and LPG at Trafigura. Further, Mrs Randi Navdal Bekkelund is appointed as Chief Financial Officer (CFO). Mrs Bekkelund has served as Finance Manager in Avance Gas AS since 2018 and prior to that 8 years in EY as an auditor for Shipping & Offshore clients and as a consultant. Lastly, it is...

Continue reading

Blitzpoker Hosts Largest Freeroll Tournament in India’s History and Sets Player and Revenue Records

TORONTO, Sept. 07, 2020 (GLOBE NEWSWIRE) — i3 Interactive Inc. (“i3 Interactive” or the “Company”) (CSE: BETS) (FRA: F0O3), is pleased to report that “Blitzpoker”, the Indian poker brand presently known as FTR Poker, and which the Company is in the midst of acquiring interests in pursuant to the terms outlined in the previously announced press release on August 10, 2020, ran the largest poker freeroll tournament in India’s history on August 22, 2020. The tournament attracted 9,503 registrations and offered several invaluable prizes, including a trip with Dan Bilzerian. The Indian poker brand has been an undeniable success – and the August customer acquisition numbers and daily revenue numbers have broken records for the brand. Since the proposed acquisition of FTR Poker has been announced, Blitzpoker has grown registrations by nearly...

Continue reading

AB Science to present results from its Phase 2B/3 AB07002 study in progressive forms of multiple sclerosis at MSVirtual2020: 8th Joint ACTRIMS-ECTRIMS Meeting

Paris, September 07, 2020, 7.30amAB Science to present results from its Phase 2B/3 AB07002 study in progressive forms of multiple sclerosis at MSVirtual2020: 8th Joint ACTRIMS-ECTRIMS Meeting  AB Science SA (Euronext – FR0010557264 – AB) today announced that an abstract reporting results from its Phase 2B/3 AB07002 study in primary progressive (PPMS) and non-active secondary progressive (nSPMS) multiple sclerosis, has been selected for a platform presentation during the 8th Joint Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) – European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Meeting, taking place September 11-13, 2020. Due to the current COVID-19 pandemic, the 2020 Joint ACTRIMS-ECTRIMS Meeting will move to a virtual format this year – MSVirtual2020.Patrick...

Continue reading

AB Science présentera les résultats de son étude de phase 2B/3 AB07002 dans les formes progressives de la sclérose en plaques à la 8ème réunion conjointe ACTRIMS-ECTRIMS (MSVirtual2020)

Paris, 7 septembre 2020, 7h30AB Science présentera les résultats de son étude de phase 2B/3 AB07002dans les formes progressives de la sclérose en plaques à la 8ème réunion conjointe ACTRIMS-ECTRIMS (MSVirtual2020)   AB Science SA (Euronext – FR0010557264 – AB) annonce aujourd’hui qu’un résumé des résultats de son étude de phase 2B/3 AB07002 dans la sclérose en plaques progressive primaire (PPMS) et la sclérose en plaques secondairement progressive non-active (nSPMS) a été sélectionné pour une présentation à la 8ème réunion conjointe de l’Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) et de l’European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), qui aura lieu du 11 au 13 septembre 2020. En raison de la pandémie actuelle du COVID-19, la réunion conjointe ACTRIMS-ECTRIMS...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.